Heterologous human/rat HER2-specific exosome-targeted T cell vaccine stimulates potent humoral and CTL responses leading to enhanced circumvention of HER2 tolerance in double transgenic HLA-A2/HER2 mice

Authors:

Abstract
No abstract available
Funding Information
  • Saskatchewan Cancer Agency (1-417521)
  • National Natural Science Foundation of China (81372443)
  • Science and Technology Department of Jiangsu Province (BY2015039-03)
  • Health and Family Planning Commission of Jiangsu Province (LGY2016030)

This publication has 48 references indexed in Scilit: